Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Dow
Harvard Business School
Cantor Fitzgerald
QuintilesIMS
US Department of Justice
Deloitte
Fish and Richardson
Fuji

Generated: April 24, 2018

DrugPatentWatch Database Preview

VEXOL Drug Profile

« Back to Dashboard

Which patents cover Vexol, and when can generic versions of Vexol launch?

Vexol is a drug marketed by Alcon and is included in one NDA.

The generic ingredient in VEXOL is rimexolone. There is one drug master file entry for this compound. Additional details are available on the rimexolone profile page.
Summary for VEXOL
US Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: 11
Patent Applications: 156
Drug Prices:see details
DailyMed Link:VEXOL at DailyMed
Drug patent expirations by year for VEXOL
Synonyms for VEXOL
(11|A,16|A,17|A)-11-Hydroxy-16,17-dimethyl-17-(1-oxopropyl)androsta-1,4-dien-3-one
(11beta,16alpha,17beta)-11-Hydroxy-16,17-dimethyl-17-(1-oxopropyl)androsta-1,4-dien-3-one
(8S,9S,10R,11S,13S,14S,16R,17S)-11-hydroxy-10,13,16,17-tetramethyl-17-propanoyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
11|A-Hydroxy-16|A,17,21-trimethylpregna-1,4-diene-3,20-dione
11|A-Hydroxy-16|A,17|A,21-trimethyl-5|A-pregna-1,4-diene-3,20-dione
11beta-Hydroxy-16alpha,17,21-trimethyl-1,4-pregnadien-3,20-dion
11beta-Hydroxy-16alpha,17alpha-dimethyl-17-propionylandrosta-1,4-dien-3-one
49697-38-3
697R383
AB00514006
AC1NSKKX
AL 02178
AL-2178
Androsta-1,4-dien-3-one, 11-hydroxy-16,17-dimethyl-17-(1-oxopropyl)-, (11beta,16alpha,17beta)-
BDBM50103606
BPBio1_001297
BRD-K31627533-001-03-8
BSPBio_001179
CCG-221020
CHEBI:135566
CHEMBL1200617
D05729
D0D2TN
DB00896
GTPL7099
HMS1571K21
HMS2098K21
HMS2235B18
MLS002154105
NCGC00179273-01
O7M2E4264D
Org 6216
Org-6216
Prestwick0_001020
Prestwick1_001020
Prestwick2_001020
Prestwick3_001020
Rimexel
Rimexolon
Rimexolona
Rimexolona [INN-Spanish]
RIMEXOLONE
Rimexolone (sustained release intra-articular steroid suspension, Plexis, arthritis)
Rimexolone (USP/INN)
Rimexolone [USAN:USP:INN:BAN]
Rimexolonum
Rimexolonum [INN-Latin]
SCHEMBL445300
SMR001233413
SPBio_003050
SR-01000841221
SR-01000841221-2
Trimexolone
UNII-O7M2E4264D
Vexol (TN)
ZINC3945984

US Patents and Regulatory Information for VEXOL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alcon VEXOL rimexolone SUSPENSION/DROPS;OPHTHALMIC 020474-001 Dec 30, 1994 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for VEXOL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Alcon VEXOL rimexolone SUSPENSION/DROPS;OPHTHALMIC 020474-001 Dec 30, 1994 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Boehringer Ingelheim
Teva
McKesson
Express Scripts
Dow
Healthtrust
McKinsey
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.